ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Assess the Effect of Hepatic Impairment on Safinamide Pharmacokinetics

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01027169
Recruitment Status : Completed
First Posted : December 7, 2009
Last Update Posted : March 29, 2013
Sponsor:
Information provided by (Responsible Party):
Newron Pharmaceuticals SPA

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2009
  Study Completion Date : No date given